BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Idera Pharmaceuticals, Inc. Presents Data from a Multiple-Dose Phase 1 Clinical Trial of IMO-3100, Lead Drug Candidate for the Treatment of Autoimmune Diseases

  April 4, 2011

   · 

  1 min read
• Genetown

  Boston Scientific Corporation’s ION(TM) Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data

  April 4, 2011

   · 

  6 min read
• Labopharm Inc. Receives Notice From Nasdaq Regarding Minimum Market Value Of Listed Securities

  April 4, 2011

   · 

  3 min read
• Biotech Bay

  Eli Lilly and Company’s Axiron(R) (Testosterone) Topical Solution CIII Now Available in Pharmacies

  April 4, 2011

   · 

  7 min read
• Biotech Beach

  Optimer Pharmaceuticals, Inc. Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients

  April 4, 2011

   · 

  5 min read
• Business

  John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

  April 4, 2011

   · 

  2 min read
• Pharm Country

  ProStrakan Group’s ABSTRAL(R) (fentanyl) Sublingual Tablets CII, First-in-class, Sublingual, Immediate Release Opioid for Managing Breakthrough Cancer Pain, Now Available in the U.S.

  April 4, 2011

   · 

  9 min read
• Siemens Healthcare Demonstrates Strategy for Sustainable Cardiovascular Care

  April 4, 2011

   · 

  3 min read
• Drug Development

  Generex Biotechnology Corporation Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research

  April 4, 2011

   · 

  4 min read
• Data From Landmark Clinical Trial of Abbott Laboratories’s MitraClip(R) System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment

  April 4, 2011

   · 

  8 min read